MedPath

Prospective evaluation on the effects of multidisciplinary intervention on physical functions in the patients with cancer cachexia

Not Applicable
Recruiting
Conditions
gastric cancer/ colorectal cancer/ pancreatic cancer
Registration Number
JPRN-UMIN000046454
Lead Sponsor
Hitachi General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

a. Patients with contraindications to the administration of anamorelin b. Patients who are judged by the attending physician, or the department or facility to which the attending physician belongs, to be undesirable to participate in the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in physical functions after 12 weeks of anamorelin administration
Secondary Outcome Measures
NameTimeMethod
change from baseline in dietary intake, ECOG performance status(PS),lean body mass(LBM),total weight,physical functions, physical function's satisfaction,adverse events,overall survival(OS),duration of treatment, progression-free survival(PFS),objective response rateand(ORR),disease control rate(DCR),efficacy,safety,predictive factors for treatment efficacy and safety in patirnts with gastric/colorectal/pancreatic cancer by early induction of multimodel care with anamorelin administration,nutritional and excercise at each assessment period.
© Copyright 2025. All Rights Reserved by MedPath